Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program, Supporting Disease Prevention to Improve Health in Developing and Emerging Countries

Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program, Supporting Disease Prevention to Improve Health in Developing and Emerging Countries

Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program, Supporting Disease Prevention to Improve Health in Developing and Emerging Countries

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced the addition of five partners to its Global CSR Program for 2019, which contributes to the long-term health of people through disease prevention and capacity building in developing and emerging countries. Approximately 20,000 employees worldwide cast their votes, selecting five new, large-scale programs run, respectively, by City Cancer Challenge, Drugs for Neglected Diseases initiative (DNDi), SeriousFun ...